Sanuwave Health
(NASDAQ) SNWV
Sanuwave Health Financials at a Glance
Market Cap
$91.41M
Revenue (TTM)
$44.33M
Net Income (TTM)
$16.05M
EPS (TTM)
$0.33
P/E Ratio
32.52
Dividend
$0.00
Beta (Volatility)
4.47 (High)
Dividend
$0.00
Beta (Volatility)
4.47 (High)
Price
$10.40
Volume
105,832
Open
$10.56
Price
$10.40
Volume
105,832
Open
$10.56
Previous Close
$10.63
Daily Range
$10.12 - $10.79
52-Week Range
$7.53 - $46.59
Estimated Earnings Date
Aug 14, 2026
Dividend
$0.00
Beta (Volatility)
4.47 (High)
Price
$10.40
Volume
105,832
Open
$10.56
Previous Close
$10.63
Daily Range
$10.12 - $10.79
52-Week Range
$7.53 - $46.59
Estimated Earnings Date
Aug 14, 2026
SNWV News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Sanuwave Health
Industry
Healthcare Equipment and Supplies
Sector
Health CareEmployees
55
CEO
Morgan C. Frank
Website
www.sanuwave.comHeadquarters
Eden Prairie, MN 55344, US
SNWV Financials
Key Financial Metrics (TTM)
Gross Margin
75.68%
Operating Margin
6.40%
Net Income Margin
36.21%
Return on Equity
-450.56%
Return on Capital
20.11%
Return on Assets
43.26%
Earnings Yield
3.08%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$91.41M
Shares Outstanding
8.60M
Volume
105.83K
Avg. Volume
140.14K
Financials (TTM)
Gross Profit
$33.55M
Operating Income
$2.84M
EBITDA
$22.67M
Operating Cash Flow
$5.79M
Capital Expenditure
$73.00K
Free Cash Flow
$5.86M
Cash & ST Invst.
$10.78M
Total Debt
$22.16M
Sanuwave Health Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$9.62M
+3.0%
Gross Profit
$7.19M
-2.7%
Gross Margin
74.70%
N/A
Market Cap
$91.41M
N/A
Market Cap/Employee
$1.66M
N/A
Employees
55
N/A
Net Income
-$1.44M
+74.6%
EBITDA
-$581.00K
+83.6%
Quarterly Fundamentals
Total Cash
$10.78M
+26.8%
Total Debt
$22.16M
-17.5%
Accounts Receivable
$6.00M
+55.2%
Inventory
$5.90M
+8.2%
Long Term Debt
$16.28M
+2766.0%
Short Term Debt
$5.89M
-77.6%
Return on Assets
43.26%
N/A
Return on Invested Capital
15.09%
N/A
Free Cash Flow
$308.00K
+118.3%
Operating Cash Flow
$397.00K
+126.2%